BIOLASE, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Accrued Liabilities and Deferred Revenue (Tables)

Accrued Liabilities and Deferred Revenue (Tables)

3 Months Ended

Mar. 31, 2017

Accrued liabilities are comprised of the following (in thousands):

	March 31,		December 31,
	2017		2016
Payroll and benefits	$	2,164	$	2,147
Warranty accrual, current portion		973		933
Taxes		493		638
Accrued professional services		946		782
Accrued capital lease obligations, current portion		117		159
Accrued insurance premium		206		906
Other		264		213
Total accrued liabilities	$	5,163	$	5,778

Changes in Initial Product Warranty Accrual and Expenses Under Initial and Extended Warranties

Changes in the initial product warranty accrual and the expenses incurred under the Company’s initial and extended warranties for the three months ended March 31, 2017 and 2016 are included within accrued liabilities on the Consolidated Balance Sheets and were as follows (in thousands):

	Three Months Ended
	March 31,
	2017			2016
Initial warranty accrual, beginning balance	$	1,706		$	2,188
Provision for estimated warranty cost		(23	)		61
Warranty expenditures		(223	)		(189	)
		1,460			2,060
Less warranty accrual, long-term		487			973
Total warranty accrual, current portion	$	973		$	1,087

Components of Deferred Revenue

Deferred revenue is comprised of the following (in thousands):

	March 31,		December 31,
	2017		2016
Undelivered elements (training, installation, and product and support services)	$	1,075	$	1,404
Extended warranty contracts		1,499		1,487
Deferred royalties		112		142
Total Deferred Revenue		2,686		3,033
Less long-term amounts:
Deferred royalties		20		23
Total Deferred Revenue - Long-Term		20		23
Total Deferred Revenue - Current	$	2,666	$	3,010